The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence and dynamics of circulating tumor DNA (ctDNA) among patients (pts) with HER2+ breast cancer (BC) receiving neoadjuvant paclitaxel/trastuzumab/pertuzumab (THP) in the DAPHNe trial.
 
Adrienne Gropper Waks
Consulting or Advisory Role - AstraZeneca
Research Funding - Genentech (Inst); Gilead Sciences (Inst); MacroGenics (Inst); Merck (Inst)
 
Paolo Tarantino
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Genentech/Roche; Gilead Sciences; Lilly; Novartis
Research Funding - AstraZeneca
 
Tianyu Li
No Relationships to Disclose
 
Esther R. Ogayo
No Relationships to Disclose
 
Tasnim Rahman
No Relationships to Disclose
 
Molly DiLullo
No Relationships to Disclose
 
Sherif Mohamed El-Refai
Employment - Personalis
Stock and Other Ownership Interests - Personalis; Tempus
 
Charles Abbott
Employment - Personalis
Stock and Other Ownership Interests - Personalis
 
Sean Michael Boyle
Employment - Personalis
Stock and Other Ownership Interests - Personalis
Patents, Royalties, Other Intellectual Property - I have patents though my position and work at Personalis, Inc.
 
Richard Chen
Employment - Personalis
Leadership - Personalis
Stock and Other Ownership Interests - Personalis
Patents, Royalties, Other Intellectual Property - Multiple Personalis technology patents
Travel, Accommodations, Expenses - Personalis
 
Neelam Vijay Desai
Honoraria - Novartis
 
Laura Spring
Consulting or Advisory Role - AstraZeneca; Daiichi Pharma; G1 Therapeutics; Lilly; Novartis; Precede Bio; Seagen
Research Funding - Genentech/Roche; Gilead Sciences; Lilly; Merck (Inst)
 
Nadine M. Tung
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst)
 
Tari A. King
Honoraria - Exact Sciences; Genomic Health
Consulting or Advisory Role - Besins Healthcare; Exact Sciences; Genomic Health
Travel, Accommodations, Expenses - Grupo Oncoclinicas
Other Relationship - Precisca
 
Ian E. Krop
Employment - PureTech (I)
Leadership - PureTech (I)
Stock and Other Ownership Interests - PureTech (I)
Honoraria - AstraZeneca; Daiichi Sankyo
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genentech/Roche; Merck; Novartis; Seagen
Research Funding - Genentech (Inst); Macrogenics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - anti-murine CD19 monoclonal antibody licensed to PharMingen
 
Nabihah Tayob
No Relationships to Disclose
 
Elizabeth A. Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Alight Sciences; AstraZeneca; BioNTech SE; Merck; Moderna Therapeutics
Research Funding - Gilead Sciences (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck Sharpe and Dohme
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Roche/Genentech
 
Sara M. Tolaney
Consulting or Advisory Role - AADi; ARC Therapeutics; Artios Biopharmaceuticals; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Blueprint Medicines; Bristol-Myers Squibb; CytomX Therapeutics; Daiichi Sankyo; eFFECTOR Therapeutics; Eisai; Genentech; Hengrui Pharmaceutical (USA); Immunomedics/Gilead; Incyte; Infinity Pharmaceuticals; Jazz Pharmaceuticals; Lilly; Menarini Group; Merck; Natera; Novartis; OncXerna Therapeutics; Pfizer; Reveal Genomics; Sanofi; Seagen; Sumitovant Biopharma; Systimmune; Tango Therapeutics; Umoja Biopharma; Zentalis; Zetagen; Zymeworks
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Novartis (Inst); OncoPep (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Sanofi
 
Eric P. Winer
Research Funding - Genentech (Inst)
 
Heather Anne Parsons
Honoraria - Guardant Health
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Daiichi Sankyo/UCB Japan; Natera; SAGA Diagnostics; Sermonix Pharmaceuticals
Research Funding - GlaxoSmithKline (Inst); Merck (Inst); Seagen (Inst)
(OPTIONAL) Uncompensated Relationships - NeoGenomics Laboratories; SAGA Diagnostics